Somatic Mosaicism in Hemophilia A: A Fairly Common Event
AUTOR(ES)
Leuer, Marco
FONTE
The American Society of Human Genetics
RESUMO
Mutations in the large gene of clotting factor VIII (FVIII) are the most common events leading to severe human bleeding disorder. The high proportion of de novo mutations observed in this gene raises the possibility that a significant proportion of such mutations does not derive from a single germ cell but instead should be attributed to a germline or somatic mosaic originating from a mutation during early embryogenesis. The present study explores this hypothesis by using allele-specific PCR to analyze 61 families that included members who had sporadic severe hemophilia A and known FVIII gene defects. The presence of somatic mosaicisms of varying degrees (0.2%–25%) could be shown in 8 (13%) of the 61 families and has been confirmed by a mutation-enrichment procedure. All mosaics were found in families with point mutations (8 [25%] of 32 families). In the subgroup of 8 families with CpG transitions, the percentage with mosaicism increased to 50% (4 of 8 families). In contrast, no mosaics were observed in 13 families with small deletions/insertions or in 16 families with intron 22 inversions. Our data suggest that mosaicism may represent a fairly common event in hemophilia A. As a consequence, risk assessment in genetic counseling should include consideration of the possibility of somatic mosaicism in families with apparently de novo mutations, especially families with the subtype of point mutations.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1226050Documentos Relacionados
- Somatic mosaicism and female-to-female transmission in a kindred with hemophilia B (factor IX deficiency).
- Paramutation and Somatic Mosaicism in Maize
- The Relation of Germ Line Mosaicism to Somatic Mosaicism in Drosophila
- Germline and somatic mosaicism in a female carrier of Hunter disease.
- Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice.